• Science and Research

  Topline CF Trial Data for ELX-02 Expected in First Half of 2020, Eloxx Says

  Posted by Cystic Fibrosis News Moderator on March 12, 2020 at 10:08 am

  

  Eloxx Pharmaceuticals says that it expects to report in the first half of 2020 its topline data from Phase 2 trials testing ELX-02 for cystic fibrosis. Read more here.

  What did you think of this article?

  Cystic Fibrosis News Moderator replied 5 years, 3 months ago 0 Member · 0 Replies
• 0 Replies

Log In to Reply